Analysis of the clinical and biological significance of CD109 in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Adachi, Kai [1 ]
Sakurai, Yasutaka [1 ]
Kato, Takuya [1 ]
Ichinoe, Masaaki [1 ]
Murakumo, Yoshiki [1 ]
机构：
[1] Kitasato Univ, Sch Med, Dept Path, Tokyo, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P14-7-4
引用
收藏
页码：569 / 569
页数：1
相关论文
共 50 条
  • [1] Analysis of the prognostic significance of CD109 in pancreatic ductal adenocarcinoma
    Adachi, Kai
    Sakurai, Yasutaka
    Kato, Takuya
    Ichinoe, Masaaki
    Murakumo, Yoshiki
    CANCER SCIENCE, 2021, 112 : 811 - 811
  • [2] CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells
    Hatsuzawa, Yuuri
    Yamaguchi, Kazunori
    Takanashi, Tomoka
    Sato, Ikuro
    Tamai, Keiichi
    Mochizuki, Mai
    Iwai, Wataru
    Wakui, Yuta
    Abue, Makoto
    Yamamoto, Kuniharu
    Yasuda, Jun
    Mizuma, Masamichi
    Unno, Michiaki
    Sugamura, Kazuo
    PANCREATOLOGY, 2020, 20 (03) : 493 - 500
  • [3] Analysis of clinical significance of BRCAness in pancreatic ductal adenocarcinoma
    Tadehara, Masayoshi
    Kato, Takuya
    Adachi, Kai
    Sakurai, Yasutaka
    Ichinoe, Masaaki
    Murakumo, Yoshiki
    CANCER SCIENCE, 2021, 112 : 810 - 810
  • [4] Analysis of the significance of CD109 expression in gallbladder cancer
    Kogami, Taro
    Kato, Takuya
    Ichinoe, Masaaki
    Sakurai, Yasutaka
    Matsushita, Masahiro
    Kusano, Chika
    Murakumo, Yoshiki
    CANCER SCIENCE, 2025, 116 : 1679 - 1679
  • [5] Dissection of the function of CD109 in lung adenocarcinoma
    Taki, Tetsuro
    Mii, Shinji
    Shiraki, Yukihiro
    Enomoto, Atsushi
    Takahashi, Masahide
    CANCER SCIENCE, 2018, 109 : 1407 - 1407
  • [6] Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
    Hayashi, Hiromitsu
    Uemura, Norio
    Zhao, Liu
    Matsumura, Kazuki
    Sato, Hiroki
    Shiraishi, Yuta
    Baba, Hideo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Clinical implications of biological markers in pancreatic ductal adenocarcinoma
    Giovinazzo, Francesco
    Turri, Giulia
    Zanini, Sara
    Butturini, Giovanni
    Scarpa, Aldo
    Bassi, Claudio
    SURGICAL ONCOLOGY-OXFORD, 2012, 21 (04): : E171 - E182
  • [8] Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma
    Jiong Chen
    Long-Jiang Chen
    Ren-Bao Yang
    Yun-Lian Xia
    Hang-Cheng Zhou
    Wen Wu
    Yin Lu
    Li-Wei Hu
    Yue Zhao
    Medical Oncology, 2013, 30
  • [9] Clinical significance of RECK promoter methylation in pancreatic ductal adenocarcinoma
    Lu, Xiong-Xiong
    Zhang, Shu-Min
    Fang, Yuan
    Wang, Zheng-Ting
    Xie, Jun-Jie
    Zhan, Qian
    Deng, Xia-Xing
    Chen, Hao
    Jin, Jia-Bin
    Peng, Cheng-Hong
    Li, Hong-Wei
    Shen, Bai-Yong
    TUMOR BIOLOGY, 2013, 34 (06) : 3339 - 3343
  • [10] Clinical significance of MUC13 in pancreatic ductal adenocarcinoma
    Khan, Sheema
    Zafar, Nadeem
    Khan, Shabia S.
    Setua, Saini
    Behrman, Stephen W.
    Stiles, Zachary E.
    Yallapu, Murali M.
    Sahay, Peeyush
    Ghimire, Hemendra
    Ise, Tomoko
    Nagata, Satoshi
    Wang, Lei
    Wan, Jim Y.
    Pradhan, Prabhakar
    Jaggi, Meena
    Chauhan, Subhash C.
    HPB, 2018, 20 (06) : 563 - 572
12345